C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

被引：0
|
作者：
Mingkun Chen
Yunlin Ye
Baojia Zou
Suping Guo
Fangjian Zhou
Keshi Lu
Jianye Liu
Zhenzhou Xu
Hui Han
Zhuowei Liu
Yonghong Li
Kai Yao
Cundong Liu
Zike Qin
机构：
[1] State Key Laboratory of Oncology in South China,Department of Urology, Cancer Center
[2] Sun Yat-sen University,Department of Urology
[3] The Third Affiliated Hospital of Southern Medical University,Department of Urology
[4] Shenzhen Children’s Hospital,Department of Urology
[5] The Third Xiangya Hospital of Central South University,Department of Urology
[6] Hunan Cancer Hospital,Department of Radiotherapy, Cancer Center
[7] Sun Yat-sen University,undefined
来源：
Journal of Translational Medicine | / 14卷
关键词：
Bladder cancer; C14orf166; Prognosis; Cell proliferation; G1/S phase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Immunotherapeutic strategies for high-risk bladder cancer
    Sharma, Padmanee
    Old, Lloyd J.
    Allison, James P.
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : 165 - 172
  • [12] C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer
    Zhang, Weijing
    Ou, Jianping
    Lei, Fangyong
    Hou, Teng
    Wu, Shu
    Niu, Chunhao
    Xu, Liqun
    Zhang, Yanna
    TUMOR BIOLOGY, 2016, 37 (01) : 369 - 379
  • [13] BLADDER CANCER - POSSIBLE NEW HIGH-RISK OCCUPATION
    WIGLE, DT
    LANCET, 1977, 2 (8028): : 83 - 84
  • [14] Indication and timing of cystectomy in high-risk bladder cancer
    Lebret, Thierry
    Neuzillet, Yann
    CURRENT OPINION IN UROLOGY, 2012, 22 (05) : 427 - 431
  • [15] RETRACTED: Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer (Retracted Article)
    Zhou, Yan-Wu
    Li, Rong
    Duan, Chao-Jun
    Gao, Yang
    Cheng, Yuan-Da
    Zhang, Chun-Fang
    BIOSCIENCE REPORTS, 2018, 38
  • [16] Controversies in management of high-risk prostate and bladder cancer
    Loeb, Stacy
    Ribal, Maria J.
    BJU INTERNATIONAL, 2015, 116 (05) : 675 - 675
  • [17] Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion
    Xin, Feng
    Yao, Dong-Wei
    Fan, Li
    Liu, Jiu-Hua
    Liu, Xiao-Dong
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 525 - 534
  • [18] Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion
    Feng Xin
    Dong-Wei Yao
    Li Fan
    Jiu-Hua Liu
    Xiao-Dong Liu
    Clinical and Experimental Medicine, 2019, 19 : 525 - 534
  • [19] LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and EpithelialMesenchymal Transition
    Chen, Yi
    Peng, Ya
    Xu, Zhipeng
    Ge, Bo
    Xiang, Xuebao
    Zhang, Tianyu
    Gao, Li
    Shi, Hailin
    Wang, Chuang
    Huang, Jiefu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (06) : 2399 - 2410
  • [20] QFIA IN DEFINING BLADDER-CANCER RISK IN HIGH-RISK COHORTS AND MANAGEMENT OF SYMPTOMATIC BLADDER-CANCER PATIENTS
    HEMSTREET, GP
    BASS, RA
    HURST, RE
    JONES, PL
    DOGGETT, RS
    SCHULTE, PA
    RINGEN, K
    WITHERINGTON, R
    JOURNAL OF UROLOGY, 1987, 137 (04): : A216 - A216
12345